Bioavailability and pharmacokinetics of a new low molecular weight heparin (RO-11)—A three way cross-over study in healthy volunteers
- 1 April 1995
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 78 (1) , 77-86
- https://doi.org/10.1016/0049-3848(95)00036-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Low molecular weight heparinBlood, 1992
- HeparinNew England Journal of Medicine, 1991
- Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo.Journal of Clinical Investigation, 1991
- Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparinEuropean Journal of Clinical Pharmacology, 1990
- The effect of molecular weight on heparin binding to plateletsBritish Journal of Haematology, 1990
- Pharmacokinetic Studies of Standard Unfractionated Heparin, and Low Molecular Weight Heparins in the RabbitSeminars in Thrombosis and Hemostasis, 1988
- A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractionsThrombosis Research, 1987
- PKCALC: A Basic Interactive Computer Program for Statistical and Pharmacokinetic Analysis of DataDrug Metabolism Reviews, 1986
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980
- Statistical moments in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1978